Managing the toxicity of alkylating agents involves several strategies. Dose adjustment, hydration, and the use of protective agents like mesna (for cyclophosphamide-induced bladder toxicity) are common approaches. Monitoring for adverse effects and supportive care, such as blood transfusions or growth factors, can also help mitigate the toxic effects.
